Form D · Other Technology
Envision Diagnostics, Inc.
Torrance, CA · CIK 0001568697
Offering snapshot reported Mar 22, 2021 · SEC filing
- Reported sold
- $23.6M Offering amount: $23.6M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 22, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 22, 2021 | Initial | $23,593,805 | No comparison | 8 | SEC filing |
| Mar 21, 2014 | Initial | $3,835,794 | No comparison | 27 | SEC filing |
| Feb 11, 2013 | Initial | $2,178,968 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-393020
Source: Form D, filed Mar 22, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Castro | Executive |
| Paul Updike | Executive |
| Alexander Walsh | Director, Executive |
| Patrick Walsh | Director |
| Patrick Welsh | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
3625 Del Amo Blvd Suite 100
Torrance, CA, 90503
Torrance, CA, 90503